Aurinia Announces Year-Two Commitment to Patient Navigation Grant Program to Address Barriers for Individuals Living with Lupus and Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today, affirmed its commitment to individuals living with the systemic lupus erythematosus (SLE) and lupus nephritis (LN) through the...
Aurinia: Q3 Earnings Snapshot
VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Wednesday reported a loss of $50.3 million in its third quarter.
U.S. Jobs Figures Due Ahead of Labour Day
Monday U.S. Economic Lookahead Pending home sales (July) Featured Earnings Zoom Video Communications ...